Empiric therapy of bacterial infections in severe neutropenia
Open Access
- 1 April 1997
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 3, S77-S86
- https://doi.org/10.1111/j.1469-0691.1997.tb00648.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patientsEuropean Journal Of Cancer, 1995
- Viridans streptococcal bacteraemia in patients with neutropeniaThe Lancet, 1995
- Bacteremia due to viridans streptococci in neutropenic patients: A reviewThe American Journal of Medicine, 1994
- Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk FactorsClinical Infectious Diseases, 1994
- From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus PanelThe Journal of Infectious Diseases, 1990
- Gram-positive bacteraemia in granulocytopenic cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1990
- Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with GranulocytopeniaNew England Journal of Medicine, 1987
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Infection in cancer patients: A continuing associationThe American Journal of Medicine, 1986
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966